Abstract—
The aim of this work was to evaluate novel three-domain antibodies consisting of two domains specific for human tumor necrosis factor (hTNF), and of the third domain responsible for binding to myeloid cells. The additional hTNF-binding domain should serve to increase the biological activity of new antibodies. Capacity of these proteins to bind hTNF on the macrophage surface and to neutralize its biological activity in vitro was assessed.
Similar content being viewed by others
REFERENCES
Ibanez, L.I., de Filette, M., Hultberg, A., Verrips, T., Temperton, N., Weiss, R.A., Vandevelde, W., Schepens, B., Vanlandschoot, P., and Saelens, X., J. Infect. Dis., 2011, vol. 203, no. 8, pp. 1063–1072.
Wu, J., Fu, J., Zhang, M., and Liu, D., J. Hematol. Oncol., 2015, vol. 8, no.), p. 96.
Vasilenko, E.A., Mokhonov, V.V., Gorshkova, E.N., and Astrakhantseva, I.V., Mol. Biol. (Moscow), 2018, vol. 52, no. 3, pp. 323–334.
Coppieters, K., Dreier, T., Silence, K., de Haard, H., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., Van de Wiele, C., Staelens, L., Hostens, J., Revets, H., Remaut, E., Elewaut, D., and Rottiers, P., Arthritis Rheum., 2006, vol. 54, pp. 1856–1866.
Bradley, M.E., Dombrecht, B., Manini, J., Willis, J., Vlerick, D., De Taeye, S., Heede, K., Roobrouck, A., Grot, E., Kent, T.C., Laeremans, T., Steffensen, S., Van Heeke, G., Brown, Z., Charlton, S.J., and Cromie, K.D., Mol. Pharmacol., 2015, vol. 87, pp. 251–262.
Qi, J., Kan, F., Ye, X., Guo, M., Zhang, Y., Ren, G., and Li, D., Int. Immunopharmacol., 2012, vol. 14, no. 4, pp. 770–778.
Liu, M., Xie, M., Jiang, S., Liu, G., Li, L., Liu, D., and Yang, X., J. Biotechnol., 2014, vol. 186, pp. 1–12.
Kruglov, A.A., Lampropoulou, V., Fillatreau, S., and Nedospasov, S.A., J. Immunol., 2011, vol. 187, no. 11, pp. 5660–5670.
Grivennikov, S.I., Tumanov, A.V., Liepinsh, D.J., Kruglov, A.A., Marakusha, B.I., Shakhov, A.N., Murakami, T., Drutskaya, L.N., Forster, I., Clausen, B.E., Tessarollo, L., Ryffel, B., Kuprash, D.V., and Nedospasov, S.A., Immunity, 2005, vol. 22, pp. 93–104.
Winsauer, C., Kruglov, A.A., Chashchina, A.A., Drutskaya, M.S., and Nedospasov, S.A., Cytokine Growth Factor Rev., 2014, vol. 25, pp. 115–123.
Efimov, G.A., Vakhrusheva, O.A., Sazykin, A.Yu., Mufazalov, I.A., Kruglov, A.A., Kuprash, D.V., and Nedospasov, S.A., Russ. J. Immunol., 2009, vol. 3, no. 12, pp. 23–29.
Efimov, G.A., Kruglov, A.A., Khlopchatnikova, Z.V., Rozov, F.N., Mokhonov, V.V., Rose-John, S., Scheller, J., Gordon, S., Stacey, M., Drutskaya, M.S., Tillib, S.V., and Nedospasov, S.A., Proc. Natl. Acad. Sci. U. S. A., 2016, vol. 113, no. 11, pp. 3006–3011.
Hamann, J., Koning, N., Pouwels, W., Ulfman, L.H., van Eijk, M., Stacey, M., Lin, H.H., Gordon, S., and Kwakkenbos, M.J., Eur. J. Immunol., 2007, vol. 37, no. 10, pp. 2797–2802.
Mokhonov, E.S., Shilov, K.V., Korneev, K-S.N., Atretkhany, E.A., Gorshkova, A.A., Zhdanova, E.A., Vasilenko, O.S., Goryainova, D.V., Kuprash, S.V., Tillib, M.S., Drutskaya, G.A., and Efimov, S.A., Nedospasov, Russ. J. Immunol., 2016, vol. 10, no. 19, pp. 378–385.
Laemmli, U., Nature, 1970, vol. 227, pp. 680–685.
Efimov, G.A., Khlopchatnikova, Z.V., Sazykin, A.Yu., Drutskaya, M.S., Kruglov, A.A., Shilov, E.S., Kuchmii, A.A., Nedospasov, S.A., and Tillib, S.V., Russ. J. Immunol., 2012, vol. 6, no. 15, pp. 337–345.
Mokhonov, V.V., Vasilenko, E.A., Gorshkova, E.N., Astrakhantseva, I.V., Novikov, D.V., and Novikov, V.V., Biochem. Biophys. Res. Commun., 2018, vol. 499, no. 4, pp. 967–972.
Olleros, M.L., Chavez-Galan, L., Segueni, N., Bourigault, M.L., Vesin, D., Kruglov, A.A., Drutskaya, M.S., Bisig, R., Ehlers, S., Aly, S., Walter, K., Kuprash, D.V., Chouchkova, M., Kozlov, S.V., Erard, F., Ryffel, B., Quesniaux, V.F., Nedospasov, S.A., and Garcia, I., Infect Immun., 2015, vol. 83, no. 9, pp. 3612–3623.
Atretkhany, K.N., Mufazalov, I.A., Dunst, J., Kuchmiy, A., Gogoleva, V.S., Andruszewski, D., Drutskaya, M.S., Faustman, D.L., Schwabenland, M., Prinz, M., Kruglov, A.A., Waisman, A., and Nedospasov, S.A., Proc. Natl. Acad. Sci. U. S. A., 2018, vol. 115, no. 51, pp. 13 051–13 056.
Espevik, T. and Nissen-Meyer, J., J. Immunol. Methods, 1986, vol. 95, pp. 99–105.
ACKNOWLEDGMENTS
Part of the sequencing work was performed on the equipment of the Genom CEC of the IMB RAS (http://www.eimb.ru/ru1/ckp/ccu_genome_c.php).
Funding
This work was supported by the state assignment (project 6.6379.2017/8.9), Russian Foundation for Basic Research (project nos. 17-04-01478 and 17-04-01137) and RSF (project no. 19-75-30032).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
In this work, the international principles of care and use of animals were observed.
Conflict of Interests
The authors declare no conflict of interest.
Additional information
Translated by L. Onoprienko
Corresponding author: phone: +7 (831) 462-32-17; e-mail: kat802@rambler.ru.
Rights and permissions
About this article
Cite this article
Vasilenko, E.A., Gorshkova, E.N., Astrakhantseva, I.V. et al. Three-Domain Antibodies against the Tumor Necrosis Factor: Investigation of Their Biological Activity In Vitro. Russ J Bioorg Chem 46, 299–305 (2020). https://doi.org/10.1134/S1068162020030218
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162020030218